TPD52 and prostate carcinoma: We observed the expression of TPD52 in prostate tissue lysates of TRAMP mice (8, 24, 36 weeks) and the results showed that with the increase of tumor size and growth the expression of TPD52 increased which is again in favor that TPD52 is overexpressed in high stage prostate cancer (Fig. 4c).